Sabina Sanghera
Exploring the use of cost-benefit analysis to compare pharmaceutical treatments for menorrhagia
Sanghera, Sabina; Frew, Emma; Gupta, Janesh Kumar; Kai, Joe; Roberts, Tracy Elizabeth
Authors
Emma Frew
Janesh Kumar Gupta
Professor JOE KAI joe.kai@nottingham.ac.uk
Professor of Primary Care
Tracy Elizabeth Roberts
Abstract
Background: The extra-welfarist theoretical framework tends to focus on health-related quality of life, whilst the welfarist framework captures a wider notion of well-being. EQ-5D and SF-6D are commonly used to value outcomes in chronic conditions with episodic symptoms, such as heavy menstrual bleeding (clinically termed menorrhagia). Because of their narrow-health focus and the condition’s periodic nature these measures may be unsuitable. A viable alternative measure is willingness to pay (WTP) from the welfarist framework.
Objective: We explore the use of WTP in a preliminary cost-benefit analysis comparing pharmaceutical treatments for menorrhagia.
Methods: A cost-benefit analysis was carried out based on an outcome of WTP. The analysis is based in the UK primary care setting over a 24-month time period, with a partial societal perspective. Ninety-nine women completed a WTP exercise from the ex-ante (pre-treatment/condition) perspective. Maximum average WTP values were elicited for two pharmaceutical treatments, levonorgestrel-releasing intrauterine system (LNG-IUS) and oral treatment. Cost data were offset against WTP and the net present value derived for treatment. Qualitative information explaining the WTP values was also collected.
Results: Oral treatment was indicated to be the most cost-beneficial intervention costing £107 less than LNG-IUS and generating £7 more benefits. The mean incremental net present value for oral treatment compared with LNG-IUS was £113. The use of the WTP approach was acceptable as very few protests and non-responses were observed.
Conclusion: The preliminary cost-benefit analysis results recommend oral treatment as the first-line treatment for menorrhagia. The WTP approach is a feasible alternative to the conventional EQ-5D/SF-6D approaches and offers advantages by capturing benefits beyond health, which is particularly relevant in menorrhagia.
Citation
Sanghera, S., Frew, E., Gupta, J. K., Kai, J., & Roberts, T. E. (2015). Exploring the use of cost-benefit analysis to compare pharmaceutical treatments for menorrhagia. PharmacoEconomics, 33(9), https://doi.org/10.1007/s40273-015-0280-0
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 1, 2015 |
Online Publication Date | Apr 25, 2015 |
Publication Date | Sep 1, 2015 |
Deposit Date | Oct 27, 2017 |
Publicly Available Date | Oct 27, 2017 |
Journal | PharmacoEconomics |
Print ISSN | 1170-7690 |
Electronic ISSN | 1179-2027 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 33 |
Issue | 9 |
DOI | https://doi.org/10.1007/s40273-015-0280-0 |
Keywords | Cost-Benefit Analysis; Pharmaceutical Treatments; Menorrhagia; Primary Care. |
Public URL | https://nottingham-repository.worktribe.com/output/758134 |
Publisher URL | https://link.springer.com/article/10.1007%2Fs40273-015-0280-0 |
Related Public URLs | http://creativecommons.org/licenses/by-nc/4.0/ |
Contract Date | Oct 27, 2017 |
Files
Sanghera PharmacoEcon 2015.pdf
(595 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc/4.0
You might also like
Introducing genetic testing for cardiovascular disease in primary care: a qualitative study
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search